m+Medelevator.RU
← Поиск публикаций
Immunogenetics · 2022

Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Oladipo Elijah Kolawole, Akindiya Olawumi Elizabeth, Oluwasanya Glory Jesudara, Akanbi Gideon Mayowa, Olufemi Seun Elijah, Adediran Daniel Adewole, Bamigboye Favour Oluwadara, Aremu Rasidat Oyindamola, Kolapo Kehinde Temitope, Oluwasegun Jerry Ayobami, Awobiyi Hezekiah Oluwajoba, Jimah Esther Moradeyo, Irewolede Boluwatife Ayobami, Folakanmi Elizabeth Oluwatoyin, Olubodun Odunola Abimbola, Akintibubo Samuel Adebowale, Odunlami Foluso Daniel, Ojo Taiwo Ooreoluwa, Akinro Omodamola Paulina, Hezikiah Oluwaseun Samuel, Olayinka Adenike Titilayo, Abiala Grace Asegunloluwa, Idowu Akindele Felix, Ogunniran James Akinwunmi, Ikuomola Mary Omotoyinbo, Adegoke Hadijat Motunrayo, Idowu Usman Abiodun, Olaniyan Oluwaseyi Paul, Bamigboye Olutoyin Omolara, Akinde Sunday Babatunde, Babalola Musa Oladayo

Аннотация

The bacteria Vibrio cholerae causes cholera, an acute diarrheal infection that can lead to dehydration and even death. Over 100,000 people die each year as a result of epidemic diseases; vaccination has emerged as a successful strategy for combating cholera. This study uses bioinformatics tools to create a multi-epitope vaccine against cholera infection using five structural polyproteins from the V. cholerae (CTB, TCPA, TCPF, OMPU, and OMPW). The antigenic retrieved protein sequence were analyzed using BCPred and IEDB bioinformatics tools to predict B cell and T cell epitopes, respectively, which were then linked with flexible linkers together with an adjuvant to boost it immunogenicity. The construct has a theoretical PI of 6.09, a molecular weight of 53.85 kDa, and an estimated half-life for mammalian reticulocytes in vitro of 4.4 h. These results demonstrate the construct's longevity. The vaccine design was docked against the human toll-like receptor (TLR) to evaluate compatibility and effectiveness; also other additional post-vaccination assessments were carried out on the designed vaccine. Through in silico cloning, its expression was determined. The results show that it has a CAI value of 0.1 and GC contents of 58.97% which established the adequate expression and downstream processing of the vaccine construct, and our research demonstrated that the multi-epitope subunit vaccine exhibits antigenic characteristics. Additionally, we carried out an in silico immunological simulation to examine the immune reaction to an injection. Our results strongly suggest that the vaccine candidate on further validation would induce immune response against the V. cholerae infection.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты